Baseline erectile function and overall survival after radical prostatectomy

Introduction. A number of studies show an obvious connection between erectile dysfunction (ED) and the development of cardiovascular diseases (CVD), which occupy one of the leading places in the structure of mortality in cancer patients. In these circumstances, it is potentially promising to use the...

Full description

Bibliographic Details
Main Authors: E. A. Sokolov, E. I. Veliev, R. A. Veliev
Format: Article
Language:Russian
Published: State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2020-10-01
Series:Vestnik Urologii
Subjects:
Online Access:https://www.urovest.ru/jour/article/view/363
_version_ 1797272160177225728
author E. A. Sokolov
E. I. Veliev
R. A. Veliev
author_facet E. A. Sokolov
E. I. Veliev
R. A. Veliev
author_sort E. A. Sokolov
collection DOAJ
description Introduction. A number of studies show an obvious connection between erectile dysfunction (ED) and the development of cardiovascular diseases (CVD), which occupy one of the leading places in the structure of mortality in cancer patients. In these circumstances, it is potentially promising to use the erectile function (EF) status before surgery as an indicator of the general health of patients and a predictor of overall survival (OS).Purpose of the study. To study the causes of death of patients with prostate cancer (pca) after radical prostatectomy (RP) and evaluate OS depending on the preoperative EF.Materials and methods. The study is based on a series of 2642 Rp performed at one medical institution between January 2003 and December 2017. Total of 1203 patients met the inclusion criteria and were divided into two groups: 620 patients with preserved EF or mild preoperative erectile dysfunction (ED) according to the five-item International Index of Erectile Function (IIEF-5) score (group 1) and 583 patients with mild-to-moderate, moderate or severe preoperative ED (group 2). The Mann-Whitney U test and chi-square test were used for statistical analysis. Survival was assessed using the Kaplan-Meier method with a log-rank test.Results. A total of 101 deaths were observed in the study cohort; the median time to death was 72 months. Cardiovascular diseases (CVD) were the cause of death in 43.6% of patients, pc — 30.7%, other oncological diseases — 19.8%, other causes — 5.9%. There were no significant differences between the groups in age, body mass index, or degree of comorbidity. Biochemical relapse was observed in 19.8% in the group with preserved EF and 20.7% in the group with a baseline IIEF score <17 (p = 0.76). In the group with higher EF before RP, there was a tendency to higher 10- and 15-year OS: 92.8% and 83.7% versus 89.7% and 82.5%, respectively (p = 0.074). Significant differences between the groups were observed in the mortality from cVD: in the group with higher IIEF score, almost three times less patients died from CVD (12 and 32), and cardiovascular survival was 97.8% and 93.5% versus 96.7% and 91.6% after 10 and 15 years (p = 0.0014).Conclusions. A lower baseline EF is associated with higher cardiovascular mortality in patients after Rp. The preoperative IIEF-5 score could be used as one of the predictors of further cardiovascular events and OS of patients. This can be helpful in preoperative selection of patients as well as initial treatment planning.
first_indexed 2024-03-07T14:24:23Z
format Article
id doaj.art-88880b11bc504029ac05dbceeb1efac4
institution Directory Open Access Journal
issn 2308-6424
language Russian
last_indexed 2024-03-07T14:24:23Z
publishDate 2020-10-01
publisher State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation
record_format Article
series Vestnik Urologii
spelling doaj.art-88880b11bc504029ac05dbceeb1efac42024-03-06T08:56:04ZrusState Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian FederationVestnik Urologii2308-64242020-10-0183697510.21886/2308-6424-2020-8-3-69-75261Baseline erectile function and overall survival after radical prostatectomyE. A. Sokolov0E. I. Veliev1R. A. Veliev2Russian Medical Academy of Continuous Professional Education; S.P. Botkin's State Clinical HospitalRussian Medical Academy of Continuous Professional Education; S.P. Botkin's State Clinical HospitalRussian Medical Academy of Continuous Professional EducationIntroduction. A number of studies show an obvious connection between erectile dysfunction (ED) and the development of cardiovascular diseases (CVD), which occupy one of the leading places in the structure of mortality in cancer patients. In these circumstances, it is potentially promising to use the erectile function (EF) status before surgery as an indicator of the general health of patients and a predictor of overall survival (OS).Purpose of the study. To study the causes of death of patients with prostate cancer (pca) after radical prostatectomy (RP) and evaluate OS depending on the preoperative EF.Materials and methods. The study is based on a series of 2642 Rp performed at one medical institution between January 2003 and December 2017. Total of 1203 patients met the inclusion criteria and were divided into two groups: 620 patients with preserved EF or mild preoperative erectile dysfunction (ED) according to the five-item International Index of Erectile Function (IIEF-5) score (group 1) and 583 patients with mild-to-moderate, moderate or severe preoperative ED (group 2). The Mann-Whitney U test and chi-square test were used for statistical analysis. Survival was assessed using the Kaplan-Meier method with a log-rank test.Results. A total of 101 deaths were observed in the study cohort; the median time to death was 72 months. Cardiovascular diseases (CVD) were the cause of death in 43.6% of patients, pc — 30.7%, other oncological diseases — 19.8%, other causes — 5.9%. There were no significant differences between the groups in age, body mass index, or degree of comorbidity. Biochemical relapse was observed in 19.8% in the group with preserved EF and 20.7% in the group with a baseline IIEF score <17 (p = 0.76). In the group with higher EF before RP, there was a tendency to higher 10- and 15-year OS: 92.8% and 83.7% versus 89.7% and 82.5%, respectively (p = 0.074). Significant differences between the groups were observed in the mortality from cVD: in the group with higher IIEF score, almost three times less patients died from CVD (12 and 32), and cardiovascular survival was 97.8% and 93.5% versus 96.7% and 91.6% after 10 and 15 years (p = 0.0014).Conclusions. A lower baseline EF is associated with higher cardiovascular mortality in patients after Rp. The preoperative IIEF-5 score could be used as one of the predictors of further cardiovascular events and OS of patients. This can be helpful in preoperative selection of patients as well as initial treatment planning.https://www.urovest.ru/jour/article/view/363erectile functioncardiovascular diseasesoverall survivalprostate cancer
spellingShingle E. A. Sokolov
E. I. Veliev
R. A. Veliev
Baseline erectile function and overall survival after radical prostatectomy
Vestnik Urologii
erectile function
cardiovascular diseases
overall survival
prostate cancer
title Baseline erectile function and overall survival after radical prostatectomy
title_full Baseline erectile function and overall survival after radical prostatectomy
title_fullStr Baseline erectile function and overall survival after radical prostatectomy
title_full_unstemmed Baseline erectile function and overall survival after radical prostatectomy
title_short Baseline erectile function and overall survival after radical prostatectomy
title_sort baseline erectile function and overall survival after radical prostatectomy
topic erectile function
cardiovascular diseases
overall survival
prostate cancer
url https://www.urovest.ru/jour/article/view/363
work_keys_str_mv AT easokolov baselineerectilefunctionandoverallsurvivalafterradicalprostatectomy
AT eiveliev baselineerectilefunctionandoverallsurvivalafterradicalprostatectomy
AT raveliev baselineerectilefunctionandoverallsurvivalafterradicalprostatectomy